Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
Status:
Withdrawn
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Positron Emission Tomography-Computed Tomography (PET-CT) with injection of
18F-fluoroethylcholine (FEC) could be a useful tool in the evaluation and follow-up of
patients who have been diagnosed with glioblastoma multiforme (GBM) and who are treated with
radiotherapy and temozolomide by allowing, for example, the distinction of necrosis from
tumour tissue. This tool could help the clinician in making therapeutic decisions for GBM
patients.